ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 191 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,702,000 | -26.4% | 940,400 | +576.8% | 0.68% | -51.4% |
| Q4 2018 | $6,392,000 | +43.5% | 138,958 | +38.4% | 1.41% | +146.7% |
| Q3 2018 | $4,453,000 | -23.6% | 100,369 | -32.5% | 0.57% | -36.7% |
| Q2 2018 | $5,828,000 | +114.1% | 148,704 | +295.0% | 0.90% | +455.6% |
| Q1 2018 | $2,722,000 | -70.9% | 37,646 | -73.5% | 0.16% | -81.0% |
| Q4 2017 | $9,361,000 | +124.1% | 142,185 | +70.6% | 0.85% | +212.5% |
| Q3 2017 | $4,178,000 | +887.7% | 83,357 | +338.7% | 0.27% | +1087.0% |
| Q4 2015 | $423,000 | -25.3% | 19,000 | -20.8% | 0.02% | 0.0% |
| Q3 2015 | $566,000 | +22.2% | 23,990 | +379.8% | 0.02% | +21.1% |
| Q1 2015 | $463,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |